Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,918 | 45,204 | 100,444 | 178,872 | 131,329 |
| Marketable Securities | N/A | 35,798 | 177,188 | 197,676 | 510,094 |
| Receivables | 526 | 923 | 4,472 | 6,362 | 6,259 |
| Other current assets | 4,072 | 3,144 | 0 | 0 | 0 |
| TOTAL | $51,691 | $94,328 | $300,327 | $398,769 | $659,668 |
| Non-Current Assets | |||||
| PPE Net | 17,887 | 26,874 | 63,531 | 51,523 | 41,324 |
| Investments And Advances | 0 | 0 | 29,845 | 88,169 | 50,530 |
| Intangibles | 0 | 0 | 88,281 | 93,462 | 100,926 |
| Other Non-Current Assets | 32,057 | 44,118 | 80,525 | 90,000 | 86,102 |
| TOTAL | $49,944 | $70,992 | $262,182 | $323,154 | $278,882 |
| Total Assets | $101,635 | $165,320 | $562,509 | $721,923 | $938,550 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,485 | 15,259 | 22,418 | 9,759 | 12,553 |
| Accrued Expenses | 14,569 | 8,918 | 21,506 | 20,840 | 20,738 |
| TOTAL | $45,805 | $47,731 | $111,711 | $127,887 | $143,547 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,556 | 0 | 51,780 | 85,711 | 91,644 |
| Other Non-Current Liabilities | 27,186 | 34,702 | 40,193 | 45,283 | 45,533 |
| TOTAL | $33,060 | $34,702 | $155,840 | $218,693 | $297,637 |
| Total Liabilities | $78,865 | $82,433 | $267,551 | $346,580 | $441,184 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 224,710 | 178,906 | 168,483 | 145,968 | 143,251 |
| Common Shares | 2,128 | 1,781 | 1,668 | 1,459 | 1,421 |
| Retained earnings | -1,504,317 | -1,406,376 | -1,148,545 | -956,267 | -777,981 |
| Other shareholders' equity | -7,530 | -4,595 | -8,404 | -3,987 | 4,551 |
| TOTAL | $22,770 | $82,887 | $294,958 | $375,343 | $497,366 |
| Total Liabilities And Equity | $101,635 | $165,320 | $562,509 | $721,923 | $938,550 |